RxDoctor Payments Data

William Jaffe

Orthopaedic Surgery · New York, NYNPI 1215033626

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $658,783 of the $661,196 with a category attached, or 99.6%. Stryker accounts for 97.1% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2020 at $298,283 and has fallen 98.1% since, to $5,524 in 2025. Among orthopaedic surgery clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$661,196in general payments, 2019–2025

Across 223 payments — averaging $2965.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$642K
  • Omnilife Science, Inc$7K
  • Corin USA$7K
  • Conmed Corporation$6K
  • Innovation Technologies Inc$73
$7,200in research payments, 2019–2025

Across 2 payments — averaging $3600.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Corin USA$7K

What the payments were for

  • Consulting fees$658,783100%
  • Speaking & faculty fees$1240%
  • Travel & lodging$2,0390%
  • Food & beverage$2510%

General payments by program year

19
20
21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Stryker217$642,100
Omnilife Science, Inc3$6,900
Corin USA1$6,600
Conmed Corporation1$5,524
Innovation Technologies Inc1$73

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$661,196 in reported general payments places this provider in the 95th percentile of 1,079 orthopaedic surgery providers in New York.

See all orthopaedic surgery providers in New York

Most prescribed under Part D

DrugClaimsCost to plans & patients
Meloxicam11$55

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →